Innovative Cellular Therapeutics Holdings Ltd
Reporting Owner SEC Filing List

CIK: 0002095697
Form Filer Subject Company Filing Agent Date Actions
4Statement of changes in beneficial owner...Lyell Immunopharma, Inc. Broadridge Financial Solutions, Inc. /fa 07/27/2026
4Statement of changes in beneficial owner...Lyell Immunopharma, Inc. Broadridge Financial Solutions, Inc. /fa 07/27/2026
4Statement of changes in beneficial owner...Innovative Cellular Therapeutics Holdings Ltd 07/27/2026
4Statement of changes in beneficial owner...Innovative Cellular Therapeutics Holdings Ltd 07/27/2026
4Statement of changes in beneficial owner...Lyell Immunopharma, Inc. Broadridge Financial Solutions, Inc. /fa 07/20/2026
4Statement of changes in beneficial owner...Innovative Cellular Therapeutics Holdings Ltd 07/20/2026
4Statement of changes in beneficial owner...Lyell Immunopharma, Inc. Broadridge Financial Solutions, Inc. /fa 07/17/2026
4Statement of changes in beneficial owner...Innovative Cellular Therapeutics Holdings Ltd 07/17/2026
4Statement of changes in beneficial owner...Lyell Immunopharma, Inc. Broadridge Financial Solutions, Inc. /fa 07/01/2026
4Statement of changes in beneficial owner...Innovative Cellular Therapeutics Holdings Ltd 07/01/2026
Load More

Innovative Cellular Therapeutics Holdings Ltd 's Ownership Transactions

Issuer Filing
Date
Transaction
Date
Transaction
Type
Shares Price Total Amt Shares Owned